Survey Request – Please Participate
In an attempt to gather information on expedited partner therapy (EPT), the University of Rhode Island (URI), College of Pharmacy has developed a survey regarding pharmacists' familiarity and awareness of EPT as it impacts pharmacy practice. The survey should take no more than 10 minutes and is completely voluntary and anonymous. The goal of the survey is to assess pharmacists' familiarity and awareness of EPT in order to determine the type and location of training and resources that need to be made available to pharmacists. The data that is compiled will be used to develop resources and training to educate pharmacists on EPT and how it effects pharmacy practice. Any practicing pharmacist is eligible.
The research is being conducted by URI College of Pharmacy. There are no anticipated risks or benefits in being in the EPT study. Data will be analyzed anonymously and does not involve any manipulation or intervention other than collection. The participants will not be compensated for their participation.
This research has been approved by The University of Rhode Island Institutional Review Boards. The principal researcher is Kelly L. Matson, PharmD, BCPPS at the University of Rhode Island, College of Pharmacy.
We have attached the Qualtrics survey link, which should take no more than 10 minutes, and we would appreciate your participation. If you have any questions, please reply to this email.
Thank you for your time,
URI COP research team
Hello to all!
Attached is a reminder that New Hampshire Professional Health Program is available to you should the need arise. This program is completely confidential. Its purpose is to provide services to assist with potential addictions, stress or depression.
In the past, the NHPHP has worked with pharmacists and other health professionals, helping them manage these challenges while retaining their licenses in good standing.
I also hope you will take the time and join us for our open meeting after the first of the year.
Free Virtual Sessions to Collaborate on Reducing Drug Related Harms
The Harm Reduction Education and Technical Assistance (HRETA) Project recently mailed resources to retail pharmacies in New Hampshire. To support and learn from NH pharmacies, the HRETA Project is offering brief learning sessions to collaborate on what community pharmacies are doing to reduce drug related harm.
To participate in a one on one educational sessions via Zoom (approximately 10-15 minutes) please visit the HRETA website at http://mypages.unh.edu/harmreductionproject/pharmacy and click on the link to schedule this call at a time that is convenient.
Pharmacy practices that reduce drug-related harms are even more important during the COVID-19 pandemic. Due to overdose, systemic infections, and Hepatitis C, the opioid epidemic has already strained health care and emergency response resources. With resources devoted to responding to COVID-19, harm reduction practices help mitigate the opioid epidemic and in turn put less strain on health care and emergency response resources.
Linda M. Kinney, MPA
Research Project Coordinator
The Dartmouth Institute of Health Policy and Clinical Practice
Articles of Interest
Assessment of Changes in the Geographical Distribution of Opioid- Related Mortality Across the United States by Opioid Type, 1999-2016 read more
Antidepressants could lead to lifelong dependence, doctors warn, since going off them can trigger agitation, headaches, and flu-like symptoms - read more
Current Board Notice regarding a new state law which went into effect 1/1/2020 regarding all opioid prescriptions dispensed in NH pharmacies - read more
New Hampshire House passes bill allowing pharmacists to prescribe contraceptives read more
The Deadly Counterfeit Drug Trade
A Prescriber’s Guide to the New Medicare Part D Opioid Overutilization Policy for 2019 read more
Pharmacy Call to Action: FDA Drug Importation Proposal Jeopardizes Patient Safety - read more
Pharmacy Discount Cards...too good to be true? - read more
Current Board Notice regarding electronic prescriptions for controlled substances.- read more
A message from the NH Department of Health and Human Services (DHHS)
NH Hepatitis A Outbreak - read more
Pharmacy Organizations Support National Standards for Technician Education - Read More
FDA declares youth vaping epidemic, announces investigation, new enforcement. read more
SB 376 requires all pharmacies in New Hampshire that sell over the counter pseudoephedrine (PSE)/ephedrine (EPH) products to participate in NPLEx, which provides real time PSE electronic tracking in accordance with the Combat Methamphetamine Epidemic Act (CMEA).NPLEx is provided FREE of charge. Click Here for full info
Surgeon General Releases First Report Focused on Smoking Cessation in 30 Years - read more
National Institute of Health 2018 New Hampshire Report read more
Blood Pressure Recall expands again to include losartan read more
Social Media Sites: The New Wild West for Illegal Online Pharmacies read more
Deprescribing: A simple method
APhA Continues to Fight for Pharmacists’ Services in Federal Legislation
though many of you answered APhA’s calls for support and outreach, the
opioid bill passed by Congress and signed into law by President Trump
did not include any Medicare Part B coverage of pharmacists’
opioid-related services. During the development of
this year’s opioid legislative package, congressional leadership made
it clear that they would exclude measures having a significant budget
implication and therefore, the potential cost or score had been the
major barrier to the inclusion of pharmacists’ services language. While
we are admittedly extremely disappointed, our work was not in vain.
There is a better awareness and understanding in Congress and federal
agencies regarding the broad range of services—including those related
to pain management and substance use disorders— that pharmacists can
provide, and more appreciation for their value.
APhA wants to reiterate our thanks and appreciation to the thousands of you who reached out to your legislators asking for the passage of H.R. 592/S. 109, the Pharmacy and Medically Underserved Areas Enhancement Act and for related language to be added in opioid legislation.
The lack of congressional passage is not indicative of the value of our profession’s efforts nor of APhA’s efforts to inform legislators and the Administration of the importance of covering pharmacists’ services. The estimated cost of expanding patient access to pharmacists’ services has always been a concern of Members of Congress.
NHPA Mission Statement
Your NHPA website has been updated and is now smartphone friendly.
Please take the time to view the website from your laptop as well as from your smartphone.
We look forward to your comments and suggestions.